HCP
AMED

Hexagon Capital Partners’s Amedisys AMED Stock Holding History

Hexagon Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-310
Closed -$28.7K – 155
2025
Q1 		$28.7K Buy
310
+161
+108% +$14.8K 0.01% 625
2024
Q4 		$13.5K Buy
149
+112
+303% +$10.3K ﹤0.01% 918
2024
Q3 		$3.57K Sell
37
-38
-51% -$3.71K ﹤0.01% 1116
2024
Q2 		$6.88K Hold
75
– – ﹤0.01% 952
2024
Q1 		$6.91K Sell
75
-15
-17% -$1.41K ﹤0.01% 938
2023
Q4 		$8.56K Sell
90
-18
-17% -$1.68K ﹤0.01% 861
2023
Q3 		$10.1K Sell
108
-56
-34% -$5.17K ﹤0.01% 745
2023
Q2 		$15K Buy
164
+19
+13% +$1.56K ﹤0.01% 640
2023
Q1 		$10.7K Sell
145
-83
-36% -$7.18K ﹤0.01% 718
2022
Q4 		$19K Sell
228
-82
-26% -$7.39K 0.01% 557
2022
Q3 		$30K Sell
310
-26
-8% -$3.1K 0.01% 495
2022
Q2 		$35K Buy
336
+3
+0.9% +$383 0.01% 427
2022
Q1 		$57K Buy
333
+2
+0.6% +$299 0.02% 348
2021
Q4 		$54K Hold
331
– – 0.01% 350
2021
Q3 		$49K Sell
331
-137
-29% -$28.5K 0.01% 351
2021
Q2 		$115K Buy
468
+12
+3% +$3.15K 0.03% 230
2021
Q1 		$120K Sell
456
-5
-1% -$1.41K 0.03% 196
2020
Q4 		$135K Hold
461
– – 0.04% 154
2020
Q3 		$117K Buy
+461
New +$105K 0.04% 159

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Hexagon Capital Partners's AMED Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Amedisys (AMED) in Q2 2025, closing a stake of 310 shares — an estimated $28.7K sold.

Hexagon Capital Partners first reported a position in AMED in Q3 2020 and held it in 19 quarters. The position peaked at $135K in Q4 2020. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 310 Amedisys shares in Q2 2025, an estimated $28.7K.
  • Hexagon Capital Partners first reported a position in Amedisys in Q3 2020 and held it in 19 quarters.
  • Hexagon Capital Partners's Amedisys position peaked at $135K in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.